Research Management Group (RMG)

Damon Runyon Cancer Research Foundation
Damon Runyon-Rachleff Innovation Award

Unlimited applicants are permitted. For extraordinary assistant professors within the first three years of their UTL and MCL faculty appointments who can spend 80% of their time conducting research.

**NOTE: Revised amount of funding and eligibility**

The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with “high risk/high reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer.


Guidelines: Sponsor's Program Overview and Application Guidelines websites
(IMPORTANT: Before you read the sponsor's website, please see eligibility requirements below because Stanford has stricter requirements.)

Timeline:
Application deadline : July 1, 2014
Funding begins: Jan. 1, 2015


Number of applicants: unlimited  (no internal seelection process is required)

Amount of funding **REVISED**
Initial award: $150,000 per year for 2 years ($300,000 total) with an opportunity for up to 2 additional years of funding (for a total of $600,000). Continued support for years three and four will be provided to those awardees who demonstrate significant progress on their proposed research during years one and two of the award.
The Award cannot be used for indirect costs or institutional overhead.

Program:
The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with “high risk/high reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer.

The Innovation award is specifically designed to provide funding for extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field.

Eligibility (revised)

Selection criteria

Applications will be evaluated based on the following:

Questions?
Please contact Jeanne Heschele at jheschele@stanford.edu.



Stanford Medicine Resources:

Footer Links: